Secondary outcomes include serum biomarkers of SCI osteoporosis ( sclerostin , P@NP and - CTX ) , markers of immune function ( IL-@ , IL-@ , FGF@ , INF - , TNF - ) , neurological function , body composition , depression and quality of life .